Stahl Neil

EDGAR CIK 0001226689

Regeneron Pharmaceuticals, Inc. - REGN

Officer
EVP Research and Development
Direct Buys
0
$0
0 Shares
Direct Sells
2
($13.27) M
-13,234 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
08/08/2024
08/12/2024
Sell
-5,197 @ $1,084.54
($5,636,346) 50,999 (-9.25%) Direct
02/07/2024
02/08/2024
Sell
-8,037 @ $950.35
($7,637,954) 52,019 (-13.38%) Direct